TuisDGX • NYSE
add
Quest Diagnostics Inc
Vorige sluiting
$155,28
Dagwisseling
$155,57 - $160,06
Jaarwisseling
$123,04 - $165,10
Markkapitalisasie
17,86Â mjd USD
Gemiddelde volume
785,15Â k
P/V-verhouding
21,47
Dividend-opbrengs
1,88%
Primêre beurs
NYSE
In die nuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (USD) | Sep. 2024info | J/J-verandering |
|---|---|---|
Inkomste | 2,49Â mjd | 8,41% |
Bedryfskoste | 463,00Â m | 14,89% |
Netto inkomste | 226,00Â m | 0,44% |
Netto winsgrens | 9,08 | -7,35% |
Wins per aandeel | 2,30 | 3,60% |
EBITDA | 478,00Â m | 3,02% |
Effektiewe belastingkoers | 21,52% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (USD) | Sep. 2024info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 764,00Â m | 434,27% |
Totale bates | 16,10Â mjd | 19,38% |
Totale aanspreeklikheid | 9,17Â mjd | 32,13% |
Totale ekwiteit | 6,92 mjd | — |
Uitstaande aandele | 111,62 m | — |
Prys om te bespreek | 2,55 | — |
Opbrengs op bates | 5,89% | — |
Opbrengs op kapitaal | 6,86% | — |
Kontantvloei
Netto kontantverandering
| (USD) | Sep. 2024info | J/J-verandering |
|---|---|---|
Netto inkomste | 226,00Â m | 0,44% |
Kontant van bedrywe | 356,00Â m | 71,98% |
Kontant van beleggings | -1,63Â mjd | -1Â 426,17% |
Kontant van finansiering | 1,77Â mjd | 2Â 232,53% |
Netto kontantverandering | 493,00Â m | 2Â 800,00% |
Beskikbare kontantvloei | 156,38Â m | 69,97% |
Meer oor
Quest Diagnostics Incorporated is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe.
As of 2020, the company had approximately 48,000 employees, and it generated more than $7.7 billion in revenue in 2019. The company offers access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders, COVID-19, and employment and court-ordered drug testing. Wikipedia
Gestig
1967
Webwerf
Werknemers
44Â 000
